Focus: Infection Control

FDA says healthcare facilities should use safer scopes

Agency suggests companies make disposable versions


The Food and Drug Administration (FDA) said companies that make duodenoscopes should begin making disposable versions, according to an article on The New York Times website.

The agency also said that hospitals should start to transition to models with disposable components to reduce the risk of infection.

FDA tests revealed that one in 20 harbored disease-causing microbes like E. coli even after being properly cleaned.

Medical experts have urged the FDA to force manufacturers to make the scopes safer and easier to decontaminate — or to take them off the market.

Read the article.



September 6, 2019


Topic Area: Infection Control


Recent Posts

Designing for Senior Care Communities Means Designing for Everyone

No spaces can be designed for just one person, designers need to think about everyone who will occupy the space.


Harlem Hospital Legionnaires' Outbreak Highlights Cooling Tower Risks

Seven deaths linked to the cooling towers underscore the need for stricter water system monitoring and preventive maintenance in healthcare settings.


WelbeHealth Opens Two New Centers in California

The two new centers are located in Elk Grove and San Bernardino.


Healthcare Security: To Arm Or Not To Arm?

Deciding whether or not to hire armed security personnel requires that managers understand a range of critical considerations.


False Alarm at Kansas Hospital Highlights Importance of Alarm System Reliability

After a two-hour search of the hospital and nearby medical facilities, no threat was found.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.